References
-
1) Esculin ameliorates obesity-induced insulin resistance by improving adipose tissue remodeling and activating the IRS1/PI3K/AKT/GLUT4 pathway.
Product: VEGFA Antibody (#AF5131)Year: 2024Journal: J EthnopharmacolImpactFactor: 4.8DOI: 10.1016/j.jep.2023.117251PMID: 37778516 -
2) Rivaroxaban down-regulates pyroptosis and the TLR4/NF-κB/NLRP3 signaling pathway to promote flap survival.
Product: VEGFA Antibody (#AF5131)Year: 2024Journal: Int ImmunopharmacolImpactFactor: 4.8DOI: 10.1016/j.intimp.2024.111568PMID: 38266447 -
3) A new look at angiogenesis inhibition of geniposide in experimental arthritis by blocking angiopoietin-2 exocytosis.
Product: VEGFA Antibody (#AF5131)Year: 2024Journal: Phytother ResImpactFactor: 6.1DOI: 10.1002/ptr.8094PMID: 38185885 -
4) L-Borneol promotes skin flap survival by regulating HIF-1α/NF-κB pathway.
Product: VEGFA Antibody (#AF5131)Year: 2024Journal: J EthnopharmacolImpactFactor: 4.8DOI: 10.1016/j.jep.2023.117543PMID: 38056540 -
5) Geniposide alleviates imiquimod-induced psoriasis-like skin lesions in mice via inhibition of angiogenesis.
Product: VEGFA Antibody (#AF5131)Year: 2024Journal: Int ImmunopharmacolImpactFactor: 4.8DOI: 10.1016/j.intimp.2024.111923PMID: 38565041 -
6) Donepezil promotes skin flap survival through activation of the HIF-1α/VEGF signalling pathway.
Product: VEGFA Antibody (#AF5131)Year: 2024Journal: Wound Repair RegenImpactFactor: 3.8DOI: 10.1111/wrr.13176PMID: 38551210 -
7) Exploring the Efficacy of Hydroxybenzoic Acid Derivatives in Mitigating Jellyfish Toxin-Induced Skin Damage: Insights into Protective and Reparative Mechanisms.
Product: VEGFA Antibody (#AF5131)Year: 2024Journal: Mar DrugsImpactFactor: 5.4DOI: 10.3390/md22050205PMID: 38786596 -
8) Icariin accelerates bone regeneration by inducing osteogenesis-angiogenesis coupling in rats with type 1 diabetes mellitus.
Product: VEGFA Antibody (#AF5131)Year: 2024Journal: World J DiabetesImpactFactor: 4.2DOI: 10.4239/wjd.v15.i4.769PMID: 38680705 -
9) 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation.
Product: VEGFA Antibody (#AF5131)Year: 2024Journal: BiofabricationImpactFactor: 8.2DOI: 10.1088/1758-5090/ad51a6PMID: 38810618 -
10) Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: iScienceImpactFactor: 5.8DOI: 10.1016/j.isci.2023.108199PMID: 37965157 -
11) Selenium Deficiency Can Promote the Expression of VEGF and Inflammatory Factors in Cartilage Differentiation and Mediates Cartilage Injury.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: Biol Trace Elem ResImpactFactor: 3.4DOI: 10.1007/s12011-023-04003-5PMID: 38159200 -
12) Activation of aldehyde dehydrogenase-2 improves ischemic random skin flap survival in rats.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: FRONT IMMUNOLImpactFactor: 5.7DOI: 10.3389/fimmu.2023.1127610PMID: 37441072 -
13) Procyanidin B2 regulates the Sirt1/Nrf2 signaling pathway to improve random-pattern skin flap survival.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: Phytother ResImpactFactor: 6.1DOI: 10.1002/ptr.7847PMID: 37128130 -
14) Eucommia ulmoides extract attenuates angiotensin II-induced cardiac microvascular endothelial cell dysfunction by inactivating p53.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: BRAZ J PHARM SCIImpactFactor: 0.6DOI: 10.1590/s2175-97902023e22473 -
15) Accelerated Bone Reconstruction by the Yoda1 Bilayer Membrane via Promotion of Osteointegration and Angiogenesis.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: Adv Healthc MaterImpactFactor: 10DOI: 10.1002/adhm.202203105PMID: 36912184